Search for: "-LHG OTSUKA PHARMACEUTICAL CO., LTD. v. SANDOZ, INC."
Results 1 - 14
of 14
Sorted by Relevance
|
Sort by Date
15 Mar 2015, 8:48 pm
Otsuka Pharmaceutical Co., Ltd. v. [read post]
8 Nov 2023, 4:15 am
Co., Ltd. v. [read post]
8 Nov 2023, 4:15 am
Co., Ltd. v. [read post]
7 May 2012, 10:51 am
By Jason Rantanen Otsuka Pharmaceutical Co., Ltd. v. [read post]
15 Oct 2015, 6:59 am
" Otsuka Pharmaceutical Co., Ltd. v. [read post]
4 Sep 2012, 7:38 am
James Jang In Otsuka Pharmaceutical Co. v. [read post]
17 Jul 2017, 9:41 am
,Ltd. v. [read post]
25 Oct 2008, 12:03 am
Sandoz, Inc (Law360) (Hal Wegner) (Patently-O) (Patent Prospector) (PLI) Cipro (Ciprofloxacin) - US: CAFC finds no antitrust liability for Hatch-Waxman reverse payment settlements: In Re Ciproflaxacin Hydrochloride Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis (SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi… [read post]
16 Jun 2010, 3:02 pm
Sandoz, Inc. [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
27 Aug 2012, 9:31 am
Co. v. [read post]
27 Aug 2012, 9:31 am
Co. v. [read post]
4 Apr 2008, 1:00 am
- Counterfeit cash flooding the market: (Afro-IP), Debranded fakes for Liberia: an update: (Afro-IP), South African music industry blames pirates for falling sales of local artists: (Afro-IP), Plaintiff obtains interlocutory relief in patent case Sanitam Services Limited v Bins (Nairobi) Services Limited: (Afro-IP), South Africa – new patent judgments: Buckman Laboratories v Bromine Compounds; Northpark Trading 3 (Pty) Ltd v Ausplow (Pty)… [read post]
13 Jun 2008, 3:40 am
, Schering-Plough Corp – Following dispute over trade dress with Schering-Plough, Fruit of the Earth announces plan to change its package design: (IP Law360), US: Quanta and its impact on biotechnology: (Holman’s Biotech IP Blog), US: BIO files amicus brief asking CAFC to cabin in scope of KSR and hold that its obvious to try dicta does not abrogate the Deuel standard: In re Kubin: (Patently-O), US: StemCells gets patent on enriched central nervous system stem cell and… [read post]
